/

Other

/

Veloxis Pharmaceuticals, Inc.

Veloxis Pharmaceuticals, Inc.

Veloxis Pharmaceuticals, Inc.

Verified Nov 2026

Other

·

United States flag

Cary, North Carolina

·

Since 2002

Veloxis Pharmaceuticals is a specialty pharmaceutical company headquartered in Cary, North Carolina, founded in 2002, with 200–500 employees. Part of Asahi Kasei Corporation, it focuses on transplant medicine and immunocompromised patient care. The company markets ENVARSUS XR®, an extended-release tacrolimus for kidney transplant recipients, and is advancing investigational candidates in infectious disease and transplant rejection prevention.

Veloxis Pharmaceuticals, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2002

Headquarters

United States flag

Cary, North Carolina

Employees

200-500

Ownership

Veloxis Pharmaceuticals, Inc. at a glance

Employees

200-500

Founded

2002

Headquarters

Cary, North Carolina

Industries

Automotive

Electric Vehicles

Medical

Overview

Veloxis Pharmaceuticals is a specialty pharmaceutical company headquartered in Cary, North Carolina, founded in 2002, with 200–500 employees. Part of Asahi Kasei Corporation, it focuses on transplant medicine and immunocompromised patient care. The company markets ENVARSUS XR®, an extended-release tacrolimus for kidney transplant recipients, and is advancing investigational candidates in infectious disease and transplant rejection prevention.

At a glance

Attribute

Detail

Founded

2002

Headquarters

Cary, North Carolina

Employees

200-500

What Veloxis Pharmaceuticals, Inc. makes

The company employs proprietary MeltDose® technology for drug formulation and delivery, with capabilities spanning research, development, commercialization, and patient support in transplant care.

Latest developments

Facilities

Veloxis Pharmaceuticals, Inc. is headquartered in Cary, North Carolina. Public sources also reference these locations:

Company details

Veloxis operates as part of Asahi Kasei Therapeutics following its parent company's integration with Calliditas Therapeutics and Aicuris Anti-Infective Cures. Veloxis Pharmaceuticals, Inc. was founded in 2002, has an estimated 200-500 employees, and is headquartered in Cary, North Carolina.

Frequently asked questions

What does Veloxis Pharmaceuticals, Inc. do?

Veloxis Pharmaceuticals is a specialty pharmaceutical company headquartered in Cary, North Carolina, founded in 2002, with 200–500 employees. Part of Asahi Kasei Corporation, it focuses on transplant medicine and immunocompromised patient care. The company markets ENVARSUS XR®, an extended-release tacrolimus for kidney transplant recipients, and is advancing investigational candidates in infectious disease and transplant rejection prevention.

Where is Veloxis Pharmaceuticals, Inc. headquartered?

Veloxis Pharmaceuticals, Inc. is headquartered in Cary, North Carolina (2000 Regency Pkwy, Cary, North Carolina, 27518-0005).

When was Veloxis Pharmaceuticals, Inc. founded?

Veloxis Pharmaceuticals, Inc. was founded in 2002.

How big is Veloxis Pharmaceuticals, Inc.?

Veloxis Pharmaceuticals, Inc. has an estimated 200-500 employees.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Cary, North Carolina (HQ)Headquarters · United States
Cary, North Carolina (HQ)2000 Regency Pkwy, Cary, North Carolina, 27518-0005, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.